Teleflex stock falls 2.52 percent after quarterly results
Published on 09/24/2026 at 12:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Teleflex stock stood at USD 121.75 on the NYSE on September 23, 2026, down 2.52 percent from the prior close of USD 124.90. The company's second-quarter report showed sharp reported revenue growth but lower GAAP earnings per share.
Revenue grows while EPS falls
According to Business Wire, Teleflex generated USD 570.3 million in revenue from continuing operations for Q2 2026, up 28.9 percent from the prior-year period ended June 30, 2025. Pro forma adjusted constant-currency revenue growth was 4.7 percent.
The earnings comparison was less favorable. GAAP diluted EPS from continuing operations was USD 0.96 in Q2 2026, compared with USD 1.54 in Q2 2025, a decline of USD 0.58 per share.
Guidance trails analyst consensus
MarketBeat reports fiscal 2026 EPS guidance of USD 6.90 to USD 7.20 and analyst consensus of USD 7.26. The consensus therefore sits above the upper end of management guidance, leaving the earnings outlook as a key valuation issue.
The same MarketBeat report lists a consensus Hold rating from 12 analysts and an average price target of USD 152.90. That target is USD 31.15 above the September 23 price, while the rating distribution shows six Holds, four Buys, one Strong Buy and one Sell.
Stock stays below yearly high
Teleflex had a market capitalization of USD 5,389,896,850 as of September 24, 2026. Its 52-week range was USD 100.18 to USD 145.00, placing the September 23 price 16.03 percent below the yearly high.
For investors, the numbers present a clear split: reported revenue accelerated through the second quarter, but GAAP EPS declined and the company's guidance remains below consensus. That combination helps explain why the stock traded near the lower half of its yearly range after the results.
Teleflex market snapshot
- Company: Teleflex Incorporated
- Ticker: TFX
- Trading venue: NYSE
- Price: USD 121.75 as of September 23, 2026
- Market capitalization: USD 5,389,896,850 as of September 24, 2026
- 52-week range: USD 100.18-145.00 as of September 24, 2026
- Sector / Industry: Healthcare / Medical Instruments and Supplies
